MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

MindWalk Holdings Corp.NASDAQ: HYFT

Investing Cash Flow · Q3 FY2026 · quarter ended Jan 2026

Investing cash flow turns positive

Q3 FY2026 investing cash flow was CA$13.99M, compared with -CA$112K a year earlier. Trailing-twelve-month investing cash flow was CA$12.97M. Over 3 fiscal years it compounded at -46.5% a year.

Context

  • Investing cash flow amounted to 3.3% of revenue in FY2025, down 3.1 pp from a year earlier.
  • Investing cash flow grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near CA$13.99M or moves back toward the trailing-twelve-month quarterly average of CA$3.24M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJan 2026
CA$13.99M+19008.4% QoQ
Last fiscal yearApr 2025
-CA$799K-48.9% YoY
LTMJan 2026
CA$12.97M+935.9% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+12593.0%——
1 year-48.9%——
3-year CAGR-46.5%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

CAD · from the cash flow

Latest · FY2025
(799K) CAD
Year-over-year change
+48.9%

Investing Cash Flow vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +935.9% is the 2nd highest of 9, against a peer median of -47.9%.
  • Investing cash flow amounts to 70.6% of revenue for HYFT, versus a peer median of 21.3%.
HYFT Competitors
Investing Cash Flow for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALXOALX Oncology Holdings Inc.LTM Mar 2026$50.1M USD-157.3%——
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$17.23M USD+20917.1%+1721.9%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$12.97M CAD+935.9%-46.5%70.6%
BYSIBeyondSpring Inc.LTM Mar 2026$12.07M USD+91.5%-9.6%—
ATYRaTyr Pharma, Inc.LTM Mar 2026$10.86M USD-23.3%—5716.3%
FBIOFortress Biotech, Inc.LTM Mar 2026$8.96M USD+164.7%—13.5%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$243K USD-72.5%—6.2%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$109K USD-90.6%+115.1%—
CLNNClene Inc.LTM Mar 2026$39K USD-100.6%-84.3%29.1%
Peer median (excluding HYFT) —-47.9%+52.7%21.3%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income(7.34M)(16.71M)(26.56M)(27.18M)(30.23M)
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
Deferred Income Tax(83K)(336K)(926K)(1.77M)(3.94M)
Stock-Based Compensation2.75M3.08M1.94M1.54M445K
Change in Working Capital(1.02M)582K(3.28M)2.4M276.99K
Accounts Receivables(439K)163K(561K)(241K)(391.8K)
Inventory(316K)(501K)(185K)(102K)99.03K
Accounts Payables(73K)781K(1.55M)994.8K593.45K
Other Working Capital(190K)139K(976K)1.75M(23.68K)
Other Non-Cash Items1.38M(310K)2.3M15.03M21.92M
Operating Cash Flow(600K)(9.92M)(19.83M)(4.25M)(6.41M)
Capital Expenditures(1.43M)(1.26M)(1.5M)(1.4M)(799K)
Acquisitions (Net)(1.03M)(3.69M)(592K)(146K)0
Purchases of Investments00000
Sales of Investments0080K121K0
Other Investing Activities0(259K)40K(141K)0
Investing Cash Flow(2.46M)(5.21M)(1.97M)(1.56M)(799K)
Debt Repayment(772K)(962K)(1.34M)(1.34M)2.67M
Common Stock Issued44.15M3.85M716K1.75M12.23M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(5K)0612.26K0
Financing Cash Flow43.38M2.88M(621K)1.02M14.89M
Effect of Forex Changes(1.18M)455K740K(33K)(438K)
Net Change in Cash39.15M(11.79M)(21.68M)(4.82M)7.25M
Free Cash Flow(2.03M)(11.18M)(21.33M)(5.64M)(7.21M)

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.